Table 1 Incidence of metastasis to the esophagus in autopsy cases (1979–88, National Cancer Center Hospital, Tokyo) From: Metastatic Esophageal Tumors.

Slides:

Advertisements

Similar presentations

Radioactive Iodine Refractory Patients : Definition and Treatment of Radioactive Iodine Refractory Thyroid Cancer Patients 방사성 옥소치료에 내성을 가진 갑상선암의 진단과 치료에.

Advertisements

Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.

ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.

1 times table 2 times table 3 times table 4 times table 5 times table

Phyllodes breast tumor

Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,

Is Cancer a Disease of Self-Seeding? Larry Norton Joan Massagué presented by: Giulia Dulá and Alina Gatowski.

Differentials. INFLAMMATORY Pulmonary Tuberculosis History of cough Chest X-ray findings (+) PPD test.

Evidence Based Approach 5-Year Survival Rate for Breast Cancer Stage IV is 14% 2 to 5 percent become long-term survivors, possibly cured of their disease.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Tables Learning Support

Staging System and Excision Types Tae Won Kim, MD PCOM Tumor Review

Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Comparison Between Definitive Chemoradiotherapy and Esophagectomy in Patients With Clinical Stage I Esophageal Squamous Cell Carcinoma Sachiko Yamamoto MD,

Treatment of superficial neoplastic lesion of esophagus

Fig. 6. Neural compression: 59-year-old man with esophageal cancer visited for weakness of both lower extremities. Sagittal T1-weighted (TR/TE; 661/10)

Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.

The IASLC Lung Cancer Staging Project The 8th Edition

Comparison of Conventional and Wire Mesh Expandable Prostheses and Surgical Bypass in Patients With Malignant Esophagorespiratory Fistulas Donald E.

Chemotherapy for Liver Metastasis Originating from Colorectal Cancer with Portal Vein Tumor Thrombosis: A Case Report Case Rep Oncol 2013;6:

Metastatic Disease in the Stomach

Table 1 Symptoms and signs at presentation

Fig. 4. Follow-up abdominal computed tomography scans after six cycles of S-1/cisplatin combination chemotherapy (A, B) and 68 months after surgery (C,

Figure 2. Kaplan–Meier survival analysis in patients

Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report Fernando Gabriel Wright, Agustin Duro, Juan Rodolfo Medici,

Fig. 5. Histopathological study of the tumor tissue removed from patient 2. A, Macroscopic view of a tumor slice showing a dense tissue occupying the center.

Study of ascites within palliative care cancer patients in Mongolia

Figure 1. MORT gene silencing is early event in cancer

Figure 1. (a) Regional computed tomography (CT) showed two distinctive patterns of low and iso density mass. (b) Gross finding of the resected specimen.

Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like.

Supplementary Figure S2

Figure 3 Response after appearance of a new lesion

Nat. Rev. Clin. Oncol. doi: /nrclinonc

An unusual presentation of esophageal metastasis from breast cancer

Van’t Veer et al, Nature 415: (2002)

Successful Treatment with S-1 and Oxaliplatin Combination Therapy in an Elderly Patient with Metastatic Colorectal Cancer Initially Presenting with Membranous.

Metastasis gets site specific

Figure 2 The association between CD8+ T‑cell density of the tumour

Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy Takashi Akaishi, MD, Iwao Kaneda, MD, Norio Higuchi, MD, Yoshiki Kuriya,

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Volume 4, Issue 1, Pages 4-6 (July 2003)

Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer Dipok Kumar Dhar, PhD, Shinji Hattori, MD, Yasuhito Tonomoto,

Role of Positron Emission Tomography in Staging Esophageal Cancer

Clinical responses in patients.

Reprogramming Enhancers to Drive Metastasis

Tumor Self-Seeding: Bidirectional Flow of Tumor Cells

A Different Method in Diagnosis of Multiple Primary Lung Cancer

Multiple Primary Cancers or Multiple Metastases, That Is the Question

3 times tables.

6 times tables.

Comparison of Conventional and Wire Mesh Expandable Prostheses and Surgical Bypass in Patients With Malignant Esophagorespiratory Fistulas Donald E.

Figure 3 Determination of the primary site

Daniel A. Anaya, MD, Mujun Yu, MD, Riyad Karmy-Jones, MD

Healthy volunteers (n=28) P value CRC patients 　　　　　　　 (n=30) ±9.3

IL6 mRNA is not detected in metastatic prostate cancer cells.

Accelerated metastasis spread in tumor-bearing mice treated with paclitaxel and anakinra. Accelerated metastasis spread in tumor-bearing mice treated with.

MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting Sox2. MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting.

Experimental metastasis inhibition by primary tumors is mediated by NK cells and IFNγ. Experimental metastasis inhibition by primary tumors is mediated.

EN1 expression in breast cancer and clinical outcome.

Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.

Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.

Location of the ER mutations and frequencies per cohort.

Macroscopic observations of the mogamulizumab-induced skin-related AEs

The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.

Detection of E-cadherin fragments in human prostate cancer metastases.

Inhibition of spontaneous pulmonary metastasis and prolonged survival after removal of primary tumor and intratracheal delivery of rAAV2/5-VAS. Inhibition.

Presentation transcript:

Table 1 Incidence of metastasis to the esophagus in autopsy cases (1979–88, National Cancer Center Hospital, Tokyo) From: Metastatic Esophageal Tumors from Distant Primary Lesions: Report of Three Esophagectomies and Study of 1835 Autopsy Cases Jpn J Clin Oncol. 1997;27(6):410-414. doi:10.1093/jjco/27.6.410 Jpn J Clin Oncol |

Table 2 Macroscopic type observed on the esophagrams From: Metastatic Esophageal Tumors from Distant Primary Lesions: Report of Three Esophagectomies and Study of 1835 Autopsy Cases Jpn J Clin Oncol. 1997;27(6):410-414. doi:10.1093/jjco/27.6.410 Jpn J Clin Oncol |